PGK1 and benign prostatic hyperplasia: Studies that explore the cognitive ability of tamsulosin, an α1-AR antagonist also used to treat BPH, but does not contain the quinazoline pharmacophore and is somewhat selective for the α1A-AR subtype, have shown that it does not bind and activate PGK1 and displays opposite cognitive functions compared to quinazoline α1-AR antagonists.